Patient Stories

Prescribing information is available at the bottom of this page.

Cresemba may be an appropriate treatment option for a range of different patients; for example, patients in need of oral therapy, those at risk of particular drug-drug interactions or those with renal impairment.

Click on the below patient profile to access and review the different patient types for whom Cresemba may be appropriate:

Ellen  

 

 

Sharing clinical experience of Cresemba® (isavuconazole) in the UK

Nelun Perera, Consultant Microbiologist
 


Footnotes
AML acute myeloid leukaemia, HIV human immunodeficiency virus, CLL chronic lymphocytic leukaemia 

Reference

1. CRESEMBA Summary of Product Characteristics.

Prescribing Information

This includes legal category, basic NHS cost and a link to SPC. Please click each relevant SPC link to be directed to EMC website.

Cresemba® (isavuconazole)
Cresemba® 100mg hard capsules –
 SPC
Legal Category: POM. Basic NHS Cost:14 caps pack £599.28
Cresemba® 200mg powder for concentrate for solution for infusion –
 SPC
Legal Category: POM Basic NHS Cost: 1 vial pack £297.84

Vfend® (voriconazole)
Vfend® 50mg filmed tablets – SPC
Legal Category: POM. Basic NHS Cost: 28 tabs £275.68
Vfend® 200mg filmed tablets – SPC
Legal Category: POM. Basic NHS Cost: 28 tabs £1102.74
Vfend® 200mg powder for solution for infusion – SPC
Legal Category: POM. Basic NHS Cost: 1 vial £77.14
Vfend® 40mg/ml Powder for oral suspension – SPC
Legal Category: POM Basic NHS Cost: 75ml £551.37

Meronem® IV (meropenem trihydrate)
Meronem® IV 1g – SPC
Legal Category: POM. Basic NHS Cost: 10 vial pack £206.28
Meronem® IV 500mg – SPC 
Legal Category: POM. Basic NHS Cost: 10 vial pack £103.14

 

PP-CRB-GBR-0821.  October 2020